Genetic and family history based cancer testing guide UK
Cancer Screening

Genetic & Family History Based Cancer Testing Guide UK

Family history can be one of the strongest risk indicators in cancer screening. Understanding inherited risk can support earlier, more informed action.

Health Screening Clinic 21 March 2026 15 min read

Genetic and family history-based cancer testing refers to screening approaches that take into account inherited risk factors when assessing an individual’s likelihood of developing certain cancers. Family history is widely recognised as one of the strongest non-modifiable risk indicators in cancer epidemiology.

Understanding your family’s cancer history can help inform more targeted screening decisions. While genetic testing itself (such as BRCA analysis) is typically arranged through NHS genomic services or specialist genetic counselling, blood-based cancer marker screening can play a complementary role for individuals with elevated familial risk. Adults over 40 with a family history may benefit from reviewing our guide on cancer risk screening tests for adults over 40.

What Is Genetic and Family History-Based Cancer Testing?

Genetic cancer testing broadly falls into two categories:

  • Genetic testing: Laboratory analysis of DNA to identify specific inherited mutations (e.g. BRCA1, BRCA2, Lynch syndrome) that may increase cancer risk. This is usually arranged through NHS genomic medicine services or private genetics clinics.
  • Blood-based cancer marker screening: Tests that measure tumour markers (e.g. PSA, CA-125, CEA, AFP) in the blood. These can flag elevated levels that may warrant further investigation, but they are not diagnostic on their own.

At Health Screening Clinic, we offer blood-based cancer marker screening rather than genetic or BRCA testing. Our service provides testing and reporting only — results should be discussed with an appropriate healthcare professional for clinical interpretation.

Important Clarification: Our clinic offers blood-based cancer marker screening (such as PSA, CA-125, and HE4) rather than genetic or BRCA testing. Genetic testing is typically arranged through NHS genomic services or specialist genetic counselling pathways.

Why Does Family History Matter?

Family history matters because certain genetic mutations that increase cancer risk can be passed from one generation to the next. The following patterns may suggest a hereditary component:

  • First-degree relatives (parent, sibling, or child) diagnosed with cancer, particularly at a younger age (under 50)
  • Multiple cancers on the same side of the family — for women, understanding the difference between cervical and ovarian screening can help clarify next steps
  • The same type of cancer appearing in two or more generations
  • Known inherited variants in the family (e.g. BRCA1/2, Lynch syndrome, Li-Fraumeni syndrome)
  • Cancers associated with hereditary syndromes, such as colorectal cancer linked to Lynch syndrome or breast/ovarian cancer linked to BRCA mutations

It is important to note that having a family history does not mean you will develop cancer. It means your statistical risk may be higher than average, which can make proactive screening more valuable.

Genetic Testing vs Standard Cancer Screening

FeatureGenetic Testing (DNA-based)Blood-Based Cancer Marker Screening
What it testsDNA for inherited mutationsTumour markers in blood
PurposeIdentify inherited genetic riskScreen for elevated marker levels
Diagnostic?Can identify specific mutationsRisk indicator only — not diagnostic
Where availableNHS genomics / specialist labsPrivate clinics including HSC
Referral neededUsually via GP or specialistNo referral needed
CostOften covered by NHS if eligibleFee applies per test or package*

*Specific fees vary. Full pricing information is available on our website.

Who Should Consider Cancer Marker Screening Based on Family History?

  • Individuals with a first-degree relative diagnosed with cancer, particularly before age 50
  • People with multiple relatives on the same side of the family who have had cancer
  • Those with known hereditary cancer syndromes in the family (e.g. BRCA, Lynch syndrome)
  • Individuals of Ashkenazi Jewish heritage, who have a statistically higher prevalence of BRCA mutations
  • Anyone who wants proactive screening data to complement their family risk profile
  • Adults over 40 who have not had previous cancer marker blood tests

For a broader overview of available blood-based cancer markers, see our article on health screening tests that help detect cancer early. You can also explore preventive cancer screening tests you should know for wider context.

Practical Insight: Even if you have a family history of cancer, blood-based screening is not a substitute for genetic testing. The two approaches serve different purposes and can complement each other as part of a wider health monitoring strategy.

Blood-Based Cancer Markers We Screen For

  • PSA (Prostate-Specific Antigen) — May indicate prostate-related changes in men
  • CA-125 — Often associated with ovarian changes, though levels can be elevated for various reasons
  • CEA (Carcinoembryonic Antigen) — Can be elevated in colorectal, lung, and other conditions
  • AFP (Alpha-Fetoprotein) — May be associated with liver-related changes
  • CA 19-9 — Sometimes linked to pancreatic or gastrointestinal conditions
  • Full Blood Count (FBC) — Can provide information about blood cell composition that may be relevant in haematological screening

It is essential to understand that elevated tumour markers do not confirm cancer. Many benign conditions can also cause raised marker levels. Results should always be reviewed by an appropriate healthcare professional.

How Often Should You Screen?

  • Annually — For individuals with a known family history who wish to track markers over time
  • Every 6 months — Where closer monitoring has been recommended by a healthcare professional
  • One-off baseline — For anyone who wants an initial set of cancer marker results for reference

Certain hormonal imbalances can overlap with cancer-related fatigue — if persistent tiredness is a concern alongside family risk, our guide on hormonal imbalances and fatigue may be relevant.

What Do Your Results Mean?

  • Within expected range: Suggests the marker is within typical population parameters — reassuring, but does not rule out all conditions.
  • Elevated result: May warrant further investigation. Elevated markers can be caused by cancer, but also by infections, inflammation, benign growths, and other non-cancerous conditions.
  • Trends over time: Tracking marker levels across multiple screenings can be more informative than a single result.

Practical Insight: A single elevated marker does not mean cancer. Trends, clinical context, and professional interpretation are all important in understanding what results may indicate.

Frequently Asked Questions

Does family history guarantee I will get cancer?

No. Family history increases statistical risk but does not guarantee a diagnosis. Many people with family history never develop cancer, and many without family history do. Screening helps monitor risk indicators proactively.

Can blood tests detect cancer early?

Blood-based tumour markers can identify elevated levels that may warrant further investigation. However, they are screening tools and risk indicators — not diagnostic tests. Further clinical assessment is needed to confirm or rule out any condition.

Should I get genetic testing or blood marker screening?

These serve different purposes. Genetic testing identifies inherited mutations; blood marker screening measures current tumour marker levels. Depending on your family history and risk profile, one or both may be appropriate. Discuss with your GP or a genetics counsellor.

Do you offer BRCA testing at Health Screening Clinic?

No. We offer blood-based cancer marker screening (e.g. PSA, CA-125, CEA, AFP). BRCA and genetic mutation testing is typically arranged through NHS genomic services or specialist genetic counselling pathways.

What should I do if my tumour markers are elevated?

Elevated markers should be discussed with an appropriate healthcare professional. Many benign conditions can cause raised levels. Your clinician can advise whether further investigation, imaging, or specialist referral may be appropriate.

How do I know if my family history is significant enough to screen?

Generally, if you have one or more first-degree relatives diagnosed with cancer — especially at a younger age — or if there are patterns of the same cancer across generations, screening may be particularly relevant. Your GP can help assess your familial risk.

Disclaimer

This article has been produced for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Individual symptoms, health concerns, or screening results should always be assessed by an appropriate healthcare professional who can provide personalised guidance based on your specific circumstances. Health Screening Clinic provides blood-based cancer marker testing and reporting services only. We do not offer genetic testing, diagnosis, prescriptions, or treatment. Where risk appears elevated, results should be discussed with an appropriate clinician for personalised interpretation and follow-up planning. If symptoms are severe, seek urgent medical care.

Clinical Leadership

Meet Your Experts.

NMC Registered Nurse
Luciana F. F. Cirillo
Lead Clinical Nurse

Luciana F. F. Cirillo

Registered Nurse (NMC)

Our Lead Clinical Nurse, renowned for elite clinical care, painless phlebotomy, and comprehensive written reports for every patient.

NMC Registered Nurse
Clinical Governance

Our clinic operates in line with UK regulatory standards, with fully registered healthcare professionals providing safe, compliant, and high-quality care. Patients should expect nothing less.

CQC Regulatory LogoNMC Regulatory LogoGMC Regulatory Logo